EDAP TMS makes the Focal One robotic HIFU system, which uses focused ultrasound to treat prostate tissue, and sells it to urologists. FOCL reports earnings on Thu, Nov 5, 2026.
Earnings
Earnings calendar →Analyst Ratings & Price Targets
Analyst Ratings →| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Aug 25 | HC Wainwright & Co. | Reiterated | Buy | |
| Jun 2 | HC Wainwright & Co. | Reiterated | Buy |
Seasonality
How FOCL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
Whale Options Flow
90DNo whale options trades in FOCL in the last 90 days.
AI Auto Pilots
Paper tradingStreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether FOCL is in one of them and how their past FOCL trades turned out.
Macro & Market News
All StreetAlpha news →StreetAlpha hasn't covered FOCL in an article yet. Here's the latest on the wider market.
About Edap Tms SA
EDAP TMS is a medical device company based in Vaulx-en-Velin, France. Its main product is the Focal One robotic HIFU system, which uses focused ultrasound to treat prostate tissue, mainly for prostate cancer. The company sells the system to urologists and other healthcare providers. It also sells older urology products, such as lithotripsy systems, and distributes some third-party urology equipment along with related services.
- Headquarters
- 69120 Vaulx En Velin, France